Epidemiology of biopsy-proven glomerular diseases in Chinese children: A scoping review
- VernacularTitle:Epidemiology of biopsy-proven glomerular diseases in Chinese children: A scoping review
- Author:
Yetong LI
1
;
Yue YANG
;
Li ZHUO
;
Dan WU
;
Wenge LI
;
Xiaorong LIU
Author Information
- Publication Type:Journal Article
- Keywords: child and adolescent; China; glomerular disease; kidney glomerulus; renal biopsy
- From: Chronic Diseases and Translational Medicine 2022;08(4):271-280
- CountryChina
- Language:English
- Abstract: Background::Glomerular disease is the leading cause of chronic kidney disease globally. No scoping review reports have focused on China's spectrum of glomerular diseases in children. This study aimed to systematically identify and describe retrospective studies on pediatric glomerular disease based on available data on sex, age, study period, and region.Methods::Six databases were systematically searched for relevant studies from initiation to December 2021 in PubMed, Embase, Web of Science, Global Health Library, Wangfang Database, and CNKI.Results::Thirty-four studies were identified in the scoping review, including 40,430 patients with biopsy-proven diagnoses. The proportion of boys was significantly higher than that of girls. In this study, 28,280 (70%) cases were primary glomerular disease, 10,547 (26.1%) cases were diagnosed as secondary glomerular disease, and 1146 (2.8%) cases were hereditary glomerular disease. Minimal change disease is the most common glomerular disease among children in China, followed by mesangial proliferative glomerulonephritis, IgA nephropathy, and purpura nephritis. We observed increments in glomerular diseases in periods 2 (2001–2010) and 3 (2011–2021). The proportion of major glomerular diseases varies significantly in the different regions of China.Conclusion::The spectrum of pediatric glomerular diseases varied across sex, age groups, study periods, and regions, and has changed considerably over the past 30 years.
